115 related articles for article (PubMed ID: 11683823)
1. Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression.
Baan CC; van Riemsdijk-van Overbeeke IC; Balk AH; Vantrimpont PM; Mol WM; Knoop CJ; Niesters HG; Maat LP; Weimar W
Clin Transplant; 2001 Aug; 15(4):276-83. PubMed ID: 11683823
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
3. Potential cardiovascular risk factors in paediatric renal transplant recipients.
Ferraris JR; Ghezzi L; Waisman G; Krmar RT
Pediatr Nephrol; 2006 Jan; 21(1):119-25. PubMed ID: 16252106
[TBL] [Abstract][Full Text] [Related]
4. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
[TBL] [Abstract][Full Text] [Related]
5. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
Taylor DO; Barr ML; Radovancevic B; Renlund DG; Mentzer RM; Smart FW; Tolman DE; Frazier OH; Young JB; VanVeldhuisen P
J Heart Lung Transplant; 1999 Apr; 18(4):336-45. PubMed ID: 10226898
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
7. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
[TBL] [Abstract][Full Text] [Related]
8. Conversion from cyclosporine to tacrolimus improves renal function and lipid profile after cardiac transplantation.
Garlicki M; Czub P; Labuś K; Ehrlich MP; Rdzanek H
Ann Transplant; 2006; 11(1):24-7. PubMed ID: 17025026
[TBL] [Abstract][Full Text] [Related]
9. [Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
Martínez Castelao A; Ramos R; Serón D; Gil-Vernet S; Fiol C; Gómez-Gerique N; Yzaguirre MT; Hurtado I; Sabaté I; Alsina J; Grinyó JM
Nefrologia; 2002; 22(4):364-9. PubMed ID: 12369128
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
11. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
[TBL] [Abstract][Full Text] [Related]
12. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
[TBL] [Abstract][Full Text] [Related]
13. Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-beta system.
van Riemsdijk IC; Baan CC; Balk AH; Vantrimpont PM; Maat LP; Weimar W
Transplant Proc; 2002 Aug; 34(5):1864-5. PubMed ID: 12176606
[No Abstract] [Full Text] [Related]
14. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
[TBL] [Abstract][Full Text] [Related]
15. Conversion from cyclosporine A to tacrolimus in pediatric kidney transplant recipients with chronic rejection: changes in the immune responses.
Ferraris JR; Tambutti ML; Cardoni RL; Prigoshin N
Transplantation; 2004 Feb; 77(4):532-7. PubMed ID: 15084930
[TBL] [Abstract][Full Text] [Related]
16. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
Neal DA; Gimson AE; Gibbs P; Alexander GJ
Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
[TBL] [Abstract][Full Text] [Related]
18. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
19. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients.
Rostaing L; Puyoo O; Tkaczuk J; Peres C; Rouzaud A; Cisterne JM; de Preval C; Ohayon E; Durand D; Abbal M
Clin Transplant; 1999 Oct; 13(5):400-9. PubMed ID: 10515221
[TBL] [Abstract][Full Text] [Related]
20. Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience.
Cantin B; Kwok BW; Shiba N; Valantine HA; Hunt SA; Chan MC
J Heart Lung Transplant; 2003 Jul; 22(7):723-30. PubMed ID: 12873539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]